Stewart Kerr IMG_5366-2.jpg

Stewart Kerr, MBA

Cofounder

Stew recently completed his MBA at Michigan’s Ross School of Business where he pursued a Healthcare Management Concentration. Immediately prior to his MBA, Stew led a regional sales team for Axiom Global Inc.’s Life Sciences practice, which provides software and services to pharmaceutical, biotechnology and medical technology companies. He is particularly fascinated by how innovative solutions can improve customer outcomes, especially within the broader healthcare ecosystem. As such, he is focused on combining his MBA education and extensive commercial experience as a means to bring life-changing technologies to market for patients.

In his free time, Stew is an avid musician and concert-goer. He’s played in a variety of bands ranging from orchestral to jazz to rock music, and currently plays with an Ann-Arbor based cover band called “Risky Business”

Stephen.jpg

Stephen Goldberg, M.D.

Cofounder

Stephen is an Anesthesiology resident at the University of California Irvine and cofounder of MyAutO2. He attended medical school at the University of Michigan where he graduated in 2021. Stephen is passionate about his career in Anesthesia while working to develop innovative medical technologies to improve the quality and efficacy of healthcare. He is also an avid community volunteer and enjoys working with local healthcare nonprofits in his community.

In his free time, Stephen enjoys “kitchen science” and is known for making his own sour dough, kombucha, and, occasionally, beer. He also enjoys cycling, traveling, and reading when time permits.

 

Scientific Advisors

MyAutO2 is building a scientific advisory board consisting of experienced medical entrepreneurs and influential clinicians to provide key guidance and market insights throughout our development process.

Expert Consultants

MyAutO2 is fortunate to leverage the skills and expertise of several outstanding consultants with significant experience in medical device development, algorithm creation and refinement, and medical business administration.